NEWRON PHARMACEUTICALS S.P.A.
20/03/2023 07:00
EQS-News: Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
17/03/2023 07:00
EQS-News: Newron to present at the 31st European Congress of Psychiatry
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
14/03/2023 07:00
EQS-News: Newron announces 2022 financial results and provides outlook for 2023
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
16/02/2023 07:00
EQS-News: Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
03/01/2023 07:00
EQS-News: Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
15/09/2022 07:00
Newron provides H1 2022 results and updates on R&D and business activities
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
01/07/2022 07:00
Newron extends Senior Management team and strengthens commitment to ESG
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
07/06/2022 07:00
Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia (TRS) at the 33rd CINP Hybrid World Congress of Neuropsychopharmacology
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
05/04/2022 11:45
Newron announces AGM 2022 results
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
NEWRON PHARMACEUTICALS S.P.A.
15/03/2022 07:00
Newron announces 2021 financial results and provides outlook for 2022
Lire la news
Voir tous les communiqués de Newron Pharmaceuticals S.p.A.
1
2
3
4
5
6
7
8
9
10